tetano
Editor, Senior Moderator
J Am Coll Emerg Physicians Open
. 2023 Apr 10;4(2):e12935.
doi: 10.1002/emp2.12935. eCollection 2023 Apr.
Pneumomediastinum in COVID-19 disease: Clinical review with emphasis on emergency management
Ezhilkugan Ganessane[SUP] 1 [/SUP], Anandhi Devendiran[SUP] 1 [/SUP], Swetha Ramesh[SUP] 1 [/SUP], Amaravathi Uthayakumar[SUP] 1 [/SUP], Vinodha Chandrasekar[SUP] 1 [/SUP], Anuusha Subathra Sadasivam[SUP] 1 [/SUP], Balamurugan Nathan[SUP] 1 [/SUP], Manu Ayyan[SUP] 1 [/SUP]
Affiliations
Abstract
Pneumomediastinum can be primary (spontaneous) or secondary to iatrogenic, traumatic, and non-traumatic causes. The incidence of spontaneous and secondary pneumomediastinum is higher in patients with coronavirus disease 2019 (COVID-19) compared to the general population. So, pneumomediastinum should be considered in the differential diagnosis of any patient with COVID-19 presenting with chest pain and breathlessness. A high level of suspicion is required to diagnose this condition promptly. Unlike in other disease conditions, pneumomediastinum in COVID-19 has a complicated course with higher mortality in intubated patients. No guidelines exist for managing pneumomediastinum patients with COVID-19. Therefore, emergency physicians should be aware of the various treatment modalities besides conservative management for pneumomediastinum and life-saving interventions for tension pneumomediastinum.
. 2023 Apr 10;4(2):e12935.
doi: 10.1002/emp2.12935. eCollection 2023 Apr.
Pneumomediastinum in COVID-19 disease: Clinical review with emphasis on emergency management
Ezhilkugan Ganessane[SUP] 1 [/SUP], Anandhi Devendiran[SUP] 1 [/SUP], Swetha Ramesh[SUP] 1 [/SUP], Amaravathi Uthayakumar[SUP] 1 [/SUP], Vinodha Chandrasekar[SUP] 1 [/SUP], Anuusha Subathra Sadasivam[SUP] 1 [/SUP], Balamurugan Nathan[SUP] 1 [/SUP], Manu Ayyan[SUP] 1 [/SUP]
Affiliations
- PMID: 37056716
- PMCID: PMC10086517
- DOI: 10.1002/emp2.12935
Abstract
Pneumomediastinum can be primary (spontaneous) or secondary to iatrogenic, traumatic, and non-traumatic causes. The incidence of spontaneous and secondary pneumomediastinum is higher in patients with coronavirus disease 2019 (COVID-19) compared to the general population. So, pneumomediastinum should be considered in the differential diagnosis of any patient with COVID-19 presenting with chest pain and breathlessness. A high level of suspicion is required to diagnose this condition promptly. Unlike in other disease conditions, pneumomediastinum in COVID-19 has a complicated course with higher mortality in intubated patients. No guidelines exist for managing pneumomediastinum patients with COVID-19. Therefore, emergency physicians should be aware of the various treatment modalities besides conservative management for pneumomediastinum and life-saving interventions for tension pneumomediastinum.